Cargando…
Repurposing old carbon monoxide-releasing molecules towards the anti-angiogenic therapy of triple-negative breast cancer
Triple-negative breast cancer (TNBC) is defined by the lack of expression of the oestrogen and progesterone receptors and HER-2. Recently, carbon monoxide (CO) was found to behave as an important endogenous signalling molecule and to suppress VEGF receptor-2 (VEGFR-2) and protein kinase B phosphoryl...
Autores principales: | Kourti, Malamati, Westwell, Andrew, Jiang, Wen, Cai, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383690/ https://www.ncbi.nlm.nih.gov/pubmed/30800223 http://dx.doi.org/10.18632/oncotarget.26638 |
Ejemplares similares
-
Aspects of Carbon Monoxide in Form of CO-Releasing Molecules Used in Cancer Treatment: More Light on the Way
por: Kourti, Malamati, et al.
Publicado: (2017) -
Carbon Monoxide Releasing Molecule-3 Enhances Osteogenic Differentiation of Human Periodontal Ligament Stem Cells by Carbon Monoxide Release
por: Chen, Hui, et al.
Publicado: (2021) -
Anti-inflammatory activities of carbon monoxide-releasing molecules (CO-RMs) in the brain
por: Motterlini, Roberto, et al.
Publicado: (2015) -
A carbon monoxide releasing metal organic framework nanoplatform for synergistic treatment of triple-negative breast tumors
por: Cong, Yiyang, et al.
Publicado: (2022) -
Emerging concepts on the anti-inflammatory actions of carbon monoxide-releasing molecules (CO-RMs)
por: Motterlini, Roberto, et al.
Publicado: (2012)